FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
ALLOPURINOL
allopurinol
LOE Approaching
Teva
ORAL · TABLET
leukemialymphoma
1984
NDA
30/100
ALOCRIL
nedocromil sodium
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
itching associated with allergic conjunctivitis
1999
NDA
30/100
ALOMIDE
lodoxamide tromethamine
LOE Approaching
Novartis
OPHTHALMIC · SOLUTION/DROPS
1993
NDA
30/100
ALOPRIM
allopurinol
LOE Approaching
Viatris (2)
INJECTION · INJECTABLE
lymphomasolid tumor malignancies+2
1996
NDA
30/100
ALORA
estradiol
LOE Approaching
Teva
TRANSDERMAL · FILM, EXTENDED RELEASE
moderate to severe vasomotor symptoms due to menopause ()
2002
NDA
30/100
ALORA
estradiol
LOE Approaching
AbbVie
TRANSDERMAL · FILM, EXTENDED RELEASE
moderate to severe vasomotor symptoms due to menopause ()
1996
NDA
30/100
ALOXI
palonosetron hydrochloride
LOE Approaching
Helsinn
INTRAVENOUS · INJECTABLE
acute nauseavomiting associated with initial+7
2003
NDA
30/100
ALOXI
palonosetron hydrochloride
LOE Approaching
Helsinn
ORAL · CAPSULE
2008
NDA
30/100
ALPHAGAN
brimonidine tartrate
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
elevated intraocular pressure (IOP) in patients with open-angle glaucomaocular hypertension+2
1997
NDA
30/100
ALPHAGAN
brimonidine tartrate
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
elevated intraocular pressure (IOP) in patients with open-angle glaucomaocular hypertension+2
1996
NDA
30/100
ALPHAGAN P
brimonidine tartrate
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
elevated intraocular pressure (IOP) in patients with open-angle glaucomaocular hypertension+2
2005
NDA
30/100
ALPHAGAN P
brimonidine tartrate
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
elevated intraocular pressure (IOP) in patients with open-angle glaucomaocular hypertension+2
2001
NDA
30/100
ALPHATREX
betamethasone dipropionate
LOE Approaching
TOPICAL · CREAM
1984
NDA
30/100
ALPHATREX
betamethasone dipropionate
LOE Approaching
TOPICAL · OINTMENT
1984
NDA
30/100
ALREX
loteprednol etabonate
LOE Approaching
Bausch + Lomb
OPHTHALMIC · SUSPENSION/DROPS
1998
NDA
30/100
ALTACE
ramipril
LOE Approaching
Pfizer
ORAL · TABLET
hypertensionto lower blood pressure+23
2007
SMNDA
30/100
ALTACE
ramipril
LOE Approaching
Pfizer
ORAL · CAPSULE
hypertensionto lower blood pressure+23
1991
SMNDA
30/100
ALTAFLUOR BENOX
fluorescein sodium and benoxinate hydrochloride
Peak
Engine Biosciences
OPHTHALMIC · SOLUTION/DROPS
2017
NDA
30/100
ALTOPREV
lovastatin
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
risk of: -Myocardial infarction -Unstable angina -Coronary revascularization procedures (See CLINICAL PHARMACOLOGYClinical Studies)+11
2002
SMNDA
30/100
ALUPENT
metaproterenol sulfate
LOE Approaching
Boehringer Ingelheim
INHALATION · SOLUTION
1980
NDA
30/100
ALUPENT
metaproterenol sulfate
LOE Approaching
Boehringer Ingelheim
ORAL · TABLET
1974
NDA
30/100
ALUPENT
metaproterenol sulfate
LOE Approaching
Boehringer Ingelheim
INHALATION · SOLUTION
1983
NDA
30/100
ALUPENT
metaproterenol sulfate
LOE Approaching
Boehringer Ingelheim
ORAL · SYRUP
1975
NDA
30/100
ALUPENT
metaproterenol sulfate
LOE Approaching
Boehringer Ingelheim
INHALATION · AEROSOL, METERED
1973
NDA
30/100
← PreviousPage 9 of 277Next →